核医学の世界市場レポート 2025年

核医学の市場規模は、今後数年で急成長が見込まれます。2029年にはCAGR11.5％で157億7,000万米ドルに成長します。予測期間の成長は、個別化医療、腫瘍学・神経学研究、持続可能な診療、研究開発、遠隔医療サービスに起因すると考えられます。予測期間の主な動向には、放射免疫療法、ハイブリッドイメージング、人工知能（AI）、新興放射性医薬品、画像診断の進歩が含まれます。

核医学市場の成長は、心血管疾患（CVD）とがんの頻度と有病率の増加によって推進されると予測されています。心血管疾患には様々な心臓や血管の障害が含まれ、がんには制御不能な細胞増殖や他の身体部位への転移が含まれます。核医学、特に心臓核医学画像診断と治療は、CVDの迅速な診断とがんの治療に重要な役割を果たしており、しばしば手術や化学療法などの他の治療法と併用されます。2023年1月に米国がん協会（American Cancer Society Inc.）が示したように、米国における新規がん患者数は2022年の1,918,030人から1,958,310人に増加すると予想されており、核医学に対する需要の高まりを裏付けています。

慢性疾患の増加は、核医学市場の今後の成長を促進すると予測されています。慢性疾患とは、3ヶ月以上持続する病気で、時間の経過とともに悪化する可能性があります。このような慢性疾患の増加は、正確でタイムリーな診断、個別化された治療、効果的なモニタリングに対する需要を生み出しています。核医学は高度な画像診断技術と治療アプリケーションを提供し、慢性疾患の管理に不可欠なものとなっています。例えば、2023年1月、米国の国立医学図書館であるNational Center for Biotechnology Information（NCBI）は、2020年の7,152万2,000人から、2050年には世界で1億4,266万人が慢性疾患に罹患すると予測しています。その結果、慢性疾患の有病率の増加が核医学市場の成長に拍車をかけています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の核医学 PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の核医学市場：成長率分析
• 世界の核医学市場の実績：規模と成長, 2019-2024
• 世界の核医学市場の予測：規模と成長, 2024-2029, 2034F
• 世界の核医学総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の核医学市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 診断
• 治療
• 世界の核医学市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 心臓病学
• リンパ腫
• 甲状腺
• 神経学
• 腫瘍学
• その他の用途
• 世界の核医学市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院と診療所
• 診断センター
• その他のエンドユーザー
• 世界の核医学市場：診断のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 単一光子放出コンピュータ断層撮影（SPECT）
• 陽電子放出断層撮影（PET）
• ガンマカメラ
• イメージング用放射性医薬品
• その他の診断画像技術
• 世界の核医学市場：治療のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 標的治療用放射性医薬品
• ベータ放射体
• アルファ放射体
• 放射線滑膜切除術用薬剤
• その他の治療用途

第7章 地域別・国別分析

• 世界の核医学市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の核医学市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 核医学市場：競合情勢
• 核医学市場：企業プロファイル
  • Bracco Imaging S.P.A. Overview, Products and Services, Strategy and Financial Analysis
  • Lantheus Medical Imaging Inc. Overview, Products and Services, Strategy and Financial Analysis
  • NTP Radioisotopes SOC Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Eckert & Ziegler Group Overview, Products and Services, Strategy and Financial Analysis
  • Jubilant Pharma LLC Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Australian Nuclear Science & Technology Organisation
• Cardinal Health Inc.
• GE Healthcare Technologies Inc.
• Curium Pharma
• Advanced Accelerator Applications USA Inc.
• Nordion Inc.
• The Institute for Radioelements
• Eczacibasi-Monrol Nuclear Products Co.
• Siemens Healthineers AG
• Cambridge Isotope Laboratories Inc.
• Bayer AG
• Medtronic plc
• Triad Isotopes Inc.
• FUJIFILM Holdings Corporation
• Mallinckrodt Pharmaceuticals plc

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 核医学市場2029：新たな機会を提供する国
• 核医学市場2029：新たな機会を提供するセグメント
• 核医学市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Nuclear medicine is a specialized field of radiology that utilizes radioactive materials inside the body to examine and assess the overall health condition of a patient.

The main types of nuclear medicine procedures can be categorized as diagnostic and therapeutic. Diagnostic nuclear medicine involves examinations to identify specific areas of strength and weakness, helping in the diagnosis of conditions, diseases, or illnesses. Applications of nuclear medicine include cardiology, lymphoma, thyroid disorders, neurology, oncology, and various other medical fields. The end-users of nuclear medicine services typically include hospitals and clinics, diagnostic centers, and other medical facilities.

The nuclear medicine market research report is one of a series of new reports from The Business Research Company that provides nuclear medicine market statistics, including nuclear medicine industry global market size, regional shares, competitors with a nuclear medicine market share, detailed nuclear medicine market segments, market trends and opportunities, and any further data you may need to thrive in the nuclear medicine industry. This nuclear medicine market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The nuclear medicine market size has grown rapidly in recent years. It will grow from $8.93 billion in 2024 to $10.2 billion in 2025 at a compound annual growth rate (CAGR) of 14.2%. The growth in the historic period can be attributed to aging population, cancer diagnosis and staging, cardiology applications, neurological disorders, regulatory approvals.

The nuclear medicine market size is expected to see rapid growth in the next few years. It will grow to $15.77 billion in 2029 at a compound annual growth rate (CAGR) of 11.5%. The growth in the forecast period can be attributed to personalized medicine, oncology and neurology research, sustainable practices, research and development, telemedicine services. Major trends in the forecast period include radioimmunotherapy, hybrid imaging, artificial intelligence (ai), emerging radiopharmaceuticals, diagnostic imaging advancements.

The growth of the nuclear medicine market is anticipated to be propelled by the increasing frequency and prevalence of cardiovascular diseases (CVD) and cancer. Cardiovascular diseases encompass various heart and blood vessel disorders, while cancer involves uncontrolled cell growth and spread to other body parts. Nuclear medicine, particularly nuclear cardiac imaging and therapy, plays a crucial role in the prompt diagnosis of CVDs and the treatment of cancer, often used in conjunction with other therapeutic options like surgery and chemotherapy. As indicated by the American Cancer Society Inc. in January 2023, the expected rise in new cancer cases in the US to 1,958,310 from 1,918,030 in 2022 underscores the growing demand for nuclear medicine.

The growing prevalence of chronic diseases is anticipated to drive the growth of the nuclear medicine market in the future. Chronic diseases are illnesses that persist for three months or longer and may worsen over time. This rise in chronic conditions creates a demand for accurate and timely diagnostics, personalized treatment, and effective monitoring. Nuclear medicine provides advanced imaging techniques and therapeutic applications, making it an essential aspect of managing chronic diseases. For example, in January 2023, the National Center for Biotechnology Information (NCBI), a US-based National Library of Medicine, projected that there would be 142.66 million individuals with chronic diseases globally by 2050, up from 71.522 million in 2020. Consequently, the increasing prevalence of chronic diseases is fueling the growth of the nuclear medicine market.

Major companies in the nuclear medicine market are concentrating on creating innovative solutions, such as nuclear medicine cyclotrons, to enhance the production of radiopharmaceuticals and improve diagnostic imaging capabilities. Nuclear medicine cyclotrons are specialized particle accelerators that generate radioactive isotopes for medical imaging and therapy by directing high-energy particles at target materials, facilitating the synthesis of radiopharmaceuticals used in procedures like positron emission tomography (PET). For example, in January 2024, GE Healthcare China, a US-based medical technology company, launched its first batch of cyclotrons on December 1, 2023, at the Chengdu Tianfu International Bio-Town. These advanced particle accelerators play a crucial role in nuclear medicine, enabling the production of medical isotopes used in molecular imaging and therapeutic applications. This initiative aims to establish a comprehensive ecosystem for nuclear medicine, thereby enhancing capabilities in early disease detection and personalized treatment.

Leading companies in the nuclear medicine market are investing in the development of new medical imaging devices and scanners to gain a competitive advantage. Siemens Healthineers, a Germany-based healthcare company, launched the Symbia Pro.specta SPECT/CT scanner in June 2022, featuring advanced single photon emission computed tomography and computed tomography (SPECT/CT) imaging capabilities. This system, equipped with low-dose CT with up to 64 slices, automated SPECT motion correction, and an intuitive workflow, enhances the quality and accessibility of SPECT/CT imaging.

In April 2022, Mediso Ltd., a Hungary-based nuclear medicine imaging equipment manufacturer, acquired Bartec Technologies Ltd. to bolster its market position in the UK and Ireland. The acquisition leverages Bartec Technologies' resources in nuclear medicine and molecular imaging equipment and accessories, contributing to Mediso's enhanced presence in the region.

Major companies operating in the nuclear medicine market include Bracco Imaging S.P.A., Lantheus Medical Imaging Inc., NTP Radioisotopes SOC Ltd., Eckert & Ziegler Group, Jubilant Pharma LLC, Australian Nuclear Science & Technology Organisation, Cardinal Health Inc., GE Healthcare Technologies Inc., Curium Pharma, Advanced Accelerator Applications USA Inc., Nordion Inc., The Institute for Radioelements, Eczacibasi-Monrol Nuclear Products Co., Siemens Healthineers AG, Cambridge Isotope Laboratories Inc., Bayer AG, Medtronic plc, Triad Isotopes Inc., FUJIFILM Holdings Corporation, Mallinckrodt Pharmaceuticals plc, PharmaLogic Holdings Corp., Institute of Isotopes Co. Ltd., Sinotau Pharmaceuticals Limited, Isotopia Molecular Imaging Limited, SHINE Medical Technologies Inc., Global Medical Solutions LLC, Charles River Analytics Inc., Touchlight Genetics Ltd., Numares B.V., Tech-X Corporation, Karyopharm Therapeutics Inc., JSC Isotope Inc., NorthStar Medical Radioisotopes LLC

North America was the largest region in the nuclear medicine market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this nuclear medicine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

The countries covered in the nuclear medicine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The nuclear medicine market consists of sales of bone density scanning, cardiac PET perfusion, cardiac PET sarcoid. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Nuclear Medicine Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on nuclear medicine market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for nuclear medicine ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The nuclear medicine market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Diagnostic; Therapeutic
• 2) By Application: Cardiology; Lymphoma; Thyroid; Neurology; Oncology; Other Application
• 3) By End-User: Hospitals and Clinics; Diagnostic Centers; Other End Users
• Subsegments:
• 1) By Diagnostic: Single Photon Emission Computed Tomography (SPECT); Positron Emission Tomography (PET); Gamma Cameras; Radiopharmaceuticals for Imaging; Other Diagnostic Imaging Techniques
• 2) By Therapeutic: Radiopharmaceuticals for Targeted Therapy; Beta Emitters; Alpha Emitters; Radiosynovectomy Agents; Other Therapeutic Applications
• Companies Mentioned: Bracco Imaging S.P.A.; Lantheus Medical Imaging Inc.; NTP Radioisotopes SOC Ltd.; Eckert & Ziegler Group; Jubilant Pharma LLC
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Nuclear Medicine Market Characteristics

3. Nuclear Medicine Market Trends And Strategies

4. Nuclear Medicine Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Nuclear Medicine Growth Analysis And Strategic Analysis Framework

• 5.1. Global Nuclear Medicine PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Nuclear Medicine Market Growth Rate Analysis
• 5.4. Global Nuclear Medicine Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Nuclear Medicine Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Nuclear Medicine Total Addressable Market (TAM)

6. Nuclear Medicine Market Segmentation

• 6.1. Global Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Diagnostic
• Therapeutic
• 6.2. Global Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cardiology
• Lymphomia
• Thyroid
• Neurology
• Oncology
• Other Application
• 6.3. Global Nuclear Medicine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals and Clinics
• Diagnostic Centers
• Other End Users
• 6.4. Global Nuclear Medicine Market, Sub-Segmentation Of Diagnostic, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Single Photon Emission Computed Tomography (SPECT)
• Positron Emission Tomography (PET)
• Gamma Cameras
• Radiopharmaceuticals for Imaging
• Other Diagnostic Imaging Techniques
• 6.5. Global Nuclear Medicine Market, Sub-Segmentation Of Therapeutic, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Radiopharmaceuticals for Targeted Therapy
• Beta Emitters
• Alpha Emitters
• Radiosynovectomy Agents
• Other Therapeutic Applications

7. Nuclear Medicine Market Regional And Country Analysis

• 7.1. Global Nuclear Medicine Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Nuclear Medicine Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Nuclear Medicine Market

• 8.1. Asia-Pacific Nuclear Medicine Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Nuclear Medicine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Nuclear Medicine Market

• 9.1. China Nuclear Medicine Market Overview
• 9.2. China Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Nuclear Medicine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Nuclear Medicine Market

• 10.1. India Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Nuclear Medicine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Nuclear Medicine Market

• 11.1. Japan Nuclear Medicine Market Overview
• 11.2. Japan Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Nuclear Medicine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Nuclear Medicine Market

• 12.1. Australia Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Nuclear Medicine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Nuclear Medicine Market

• 13.1. Indonesia Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Nuclear Medicine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Nuclear Medicine Market

• 14.1. South Korea Nuclear Medicine Market Overview
• 14.2. South Korea Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Nuclear Medicine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Nuclear Medicine Market

• 15.1. Western Europe Nuclear Medicine Market Overview
• 15.2. Western Europe Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Nuclear Medicine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Nuclear Medicine Market

• 16.1. UK Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Nuclear Medicine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Nuclear Medicine Market

• 17.1. Germany Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Nuclear Medicine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Nuclear Medicine Market

• 18.1. France Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Nuclear Medicine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Nuclear Medicine Market

• 19.1. Italy Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Nuclear Medicine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Nuclear Medicine Market

• 20.1. Spain Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Nuclear Medicine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Nuclear Medicine Market

• 21.1. Eastern Europe Nuclear Medicine Market Overview
• 21.2. Eastern Europe Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Nuclear Medicine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Nuclear Medicine Market

• 22.1. Russia Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Nuclear Medicine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Nuclear Medicine Market

• 23.1. North America Nuclear Medicine Market Overview
• 23.2. North America Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Nuclear Medicine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Nuclear Medicine Market

• 24.1. USA Nuclear Medicine Market Overview
• 24.2. USA Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Nuclear Medicine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Nuclear Medicine Market

• 25.1. Canada Nuclear Medicine Market Overview
• 25.2. Canada Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Nuclear Medicine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Nuclear Medicine Market

• 26.1. South America Nuclear Medicine Market Overview
• 26.2. South America Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Nuclear Medicine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Nuclear Medicine Market

• 27.1. Brazil Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Nuclear Medicine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Nuclear Medicine Market

• 28.1. Middle East Nuclear Medicine Market Overview
• 28.2. Middle East Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Nuclear Medicine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Nuclear Medicine Market

• 29.1. Africa Nuclear Medicine Market Overview
• 29.2. Africa Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Nuclear Medicine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Nuclear Medicine Market Competitive Landscape And Company Profiles

• 30.1. Nuclear Medicine Market Competitive Landscape
• 30.2. Nuclear Medicine Market Company Profiles
  • 30.2.1. Bracco Imaging S.P.A. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Lantheus Medical Imaging Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. NTP Radioisotopes SOC Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Eckert & Ziegler Group Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Jubilant Pharma LLC Overview, Products and Services, Strategy and Financial Analysis

31. Nuclear Medicine Market Other Major And Innovative Companies

• 31.1. Australian Nuclear Science & Technology Organisation
• 31.2. Cardinal Health Inc.
• 31.3. GE Healthcare Technologies Inc.
• 31.4. Curium Pharma
• 31.5. Advanced Accelerator Applications USA Inc.
• 31.6. Nordion Inc.
• 31.7. The Institute for Radioelements
• 31.8. Eczacibasi-Monrol Nuclear Products Co.
• 31.9. Siemens Healthineers AG
• 31.10. Cambridge Isotope Laboratories Inc.
• 31.11. Bayer AG
• 31.12. Medtronic plc
• 31.13. Triad Isotopes Inc.
• 31.14. FUJIFILM Holdings Corporation
• 31.15. Mallinckrodt Pharmaceuticals plc

32. Global Nuclear Medicine Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Nuclear Medicine Market

34. Recent Developments In The Nuclear Medicine Market

35. Nuclear Medicine Market High Potential Countries, Segments and Strategies

• 35.1 Nuclear Medicine Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Nuclear Medicine Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Nuclear Medicine Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer